Skip navigation
Universidade de Brasília
Use este identificador para citar ou linkar para este item: http://repositorio2.unb.br/jspui/handle/10482/44935
Arquivos associados a este item:
Não existem arquivos associados a este item.
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorMorais, Karollyne da Silva-
dc.contributor.authorArcanjo, Daniel da Silva-
dc.contributor.authorLopes, Giselle Pinto de Faria-
dc.contributor.authorSilva, Guilherme Guimarães da-
dc.contributor.authorMota, Tales Henrique Andrade da-
dc.contributor.authorGabriel, Thiago Rodrigues-
dc.contributor.authorRamos, Doralina do Amaral Rabello-
dc.contributor.authorPittella-Silva, Fabio-
dc.contributor.authorOliveira, Diêgo Madureira de-
dc.date.accessioned2022-09-29T14:25:27Z-
dc.date.available2022-09-29T14:25:27Z-
dc.date.issued2019-04-23-
dc.identifier.citationMORAIS, Karollyne da Silva et al. Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells. Cell Biochemistry & Function, v. 37, p. 273-280, 2019. DOI: https://doi.org/10.1002/cbf.3398.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/44935-
dc.language.isoInglêspt_BR
dc.publisherWileypt_BR
dc.rightsAcesso Restritopt_BR
dc.titleLong-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cellspt_BR
dc.typeArtigopt_BR
dc.subject.keywordCâncerpt_BR
dc.subject.keywordTelomerasept_BR
dc.identifier.doihttps://doi.org/10.1002/cbf.3398pt_BR
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/10.1002/cbf.3398pt_BR
dc.description.abstract1Telomerase is a good target for new anticancer drug development because it is present in over 85% of human tumours. However, despite chronic therapy is a condition for anti-telomerase approach, the effects of long-term treatment with telomerase inhibitors remain not well understood. In this work, it was evaluated the effects of long-term treatment of human MDA-MB-231 breast cancer cells with the telomerase inhibitor MST-312. Cells were treated for 72 hours or 140 days, and it was accessed their viability, proliferation rate, morphology, telomeric DNA content, and resistance mechanism. The drug had a clear short-term effect, including chemosensitizing cells for docetaxel and irinotecan, but the chronic exposition led to selection of long telomeres clones, changing characteristics of original cell line. This effect was confirmed in a clonal culture with homogenous karyotype. MRP-1 expression and alternative lengthening of telomeres (ALT) were discarded as additional mechanisms of resistance. This data suggest that, considering the intra-tumour heterogeneity (ITH), what is already a big challenge for treatment of cancer, chronic exposition to telomerase inhibitors can promote tumour adaptations with potential clinical repercussion, drawing attention to ongoing clinical trials and pointing important considerations most times neglected on studies about use of these inhibitors on cancer therapy.Significance of the study:Antitumour action of telomerase inhibitors is wellknown, but it depends on a long‐term exposition because cells will undergo telomereerosion only after many duplication cycles. Recently, the frustrating results of clinicaltrials with these inhibitors aroused the interest of the scientific community to under-stand the mechanisms of resistance to anti‐telomerase therapy. In this study, we con-ducted an 18‐week experiment to show that telomerase inhibition can lead to celladaptations and selection of long‐telomeres clones, leading to acquisition of resis-tance. However, we also showed that this inhibitor can sensitize cells to the chemo-therapeutic drugs docetaxel and irinotecan.pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-6044-1954pt_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade de Ciências da Saúdept_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade de Ciências da Saúdept_BR
dc.contributor.affiliationInstituto deEstudos do Mar Almirante Paulo Moreira, Departamento de Biotecnologypt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.